« Back to Record
Citation APA

Ding, L., Gysemans, C. A., Stangé, G., Heremans, Y., Yuchi, Y., Takiishi, T., Korf, H., Chintinne, M., Carr, R. D., Heimberg, H., Pipeleers, D., & Mathieu, C. (2014). Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice. PloS one, 9(9), e107935. doi:10.1371/journal.pone.0107935


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/338063

Ding, L., Gysemans, C. A., Stangé, G., Heremans, Y., Yuchi, Y., Takiishi, T., Korf, H., Chintinne, M., Carr, R. D., Heimberg, H., Pipeleers, D., & Mathieu, C. (2014). Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice. PloS one, 9(9), e107935. doi:10.1371/journal.pone.0107935